IBJNews

Lilly Endowment funds OrthoWorx effort with $7 million

Back to TopCommentsE-mailPrintBookmark and Share

A new group expected to develop the orthopedic implants industry in Warsaw will be able to proceed now that Indianapolis-based Lilly Endowment Inc. is putting $7 million behind it, according to an announcement this morning.

The money will fund the creation of OrthoWorx, an organization dreamed up by BioCrossroads Inc., a life sciences development group based in Indianapolis.

BioCrossroads called for the creation of OrthoWorx in a Sept. 10 report, also funded by Lilly Endowment, which analyzed the strengths and challenges of Warsaw’s orthopedics hub.

The region accounts for nearly one-third of the worldwide revenue of the $32.5 billion orthopedics industry, the report determined.

Medical-device firms and the companies that serve them employ more than 6,000 people in Kosciusko County, where Warsaw is the county seat. From 2001 to 2007, employment growth in the local medical-device sector surged 39 percent.

But the Warsaw cluster faces two major challenges. First, health care reform and increased federal regulations could squeeze the profits of orthopedic-implant makers, pressuring them to outsource operations to lower-cost regions. Second, cell-regeneration and stem-cell technologies are threatening to one day render artificial hip and knee replacements unnecessary. The Warsaw companies are working to make those breakthroughs, rather than be broken by them.

Lilly Endowment will give the money to the Kosciusko County Community Foundation. The foundation will create a charitable affiliate, the Orthopedic Capital Foundation, and work to form a business league focused on the orthopedic industry.

“We are pleased that a promising plan and framework have been developed, after many months of deliberation and good effort, to secure and enhance the region’s competitive appeal to the orthopedic industry now and in the future,” N. Clay Robbins, president of the Lilly Endowment, said in a statement.
 

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
thisissue1-092914.jpg 092914

Subscribe to IBJ
ADVERTISEMENT